Navigation Links
NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012
Date:8/8/2012

stock: par value $0.001, 100,000,000 shares authorized; 59,391,169 and

56,167,090 shares issued as of June 30, 2012 and December 31, 2011, respectively

5956Additional paid-in capital

544,997489,542Accumulated deficit

(340,035)(329,828)Accumulated other comprehensive loss

(192)(68)Treasury stock, at cost: 541,584 and 480,923 shares as of June 30, 2012 and December

31, 2011, respectively

(9,551)(8,516)Total stockholders' equity

195,278151,186Total liabilities and stockholders' equity

$

302,049$

291,708 NxStage Medical, Inc.Cash Flows from Operating Activities(in thousands)(unaudited)Six Months Ended June 30,20122011Cash flows from operating activities:Net loss

$

(10,207)$

(11,560)Adjustments to reconcile net loss to net cash provided by (used in) operating activities:Depreciation and amortization

11,58011,459Stock-based compensation

6,2526,701Other

2,3451,737Changes in operating assets and liabilities:Accounts receivable

(1,851)(1,753)Inventory

(7,809)(13,363)Prepaid expenses and other assets

(170)(546)Accounts payable

(946)5,471Accrued expenses and other liabilities

3,038(2,446)Deferred revenues

(1,346)629Net cash provided by (used in) operating activities

$

886$

(3,671) NxStage Medical, Inc.Revenues by Segment(in thousands)(unaudited)Three Months Ended June 30,Six Months Ended June 30,2012201120122011System One segmentHome

$

30,693$

27,013$

60,246$

53,058Critical Care

9,3718,59119,15816,029Total System One segment

40,06435,60479,40469,087In-Center segment

18,22918,16435,84035,245Other

716—716—Total

$

59,009$

53,768$

115,960$

104,332 NxStage Medical, Inc.Non-GAAP Financial Measures(in mill
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More Frequent Home Hemodialysis with the NxStage System One
2. Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant
3. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
4. InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million
5. diaDexus, Inc. Reports Second Quarter 2012 Financial Results
6. HeartWare Reports Second Quarter 2012 Results
7. Omeros Corporation Reports Second Quarter 2012 Financial Results
8. Express Scripts Reports Second Quarter Results
9. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
10. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
11. Endo Reports Second Quarter Financial Results and Updates 2012 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Pa. , May 21, 2013  Lehigh Valley ... TRU-D SmartUVC TM devices, adding to its existing ... seven devices taking up residence within the network, LVHN ... the U.S. to proactively combat superbugs and provide the ... for Total Room Ultraviolet Disinfector, TRU-D – the signature ...
(Date:5/21/2013)... , May 21, 2013  Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...
(Date:5/21/2013)... -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: ... cell based therapies for various personal applications, announced that ... CEO, will be presenting at the Marcum MicroCap Conference.   ... Thursday, May 30, 2013 at the Grand Hyatt Hotel, ... City.  Mr. Weinreb,s presentation will take place at 2:30 ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
... , , SOUTHFIELD, Mich. ... ., (Nasdaq: TEAM ), a worldwide provider of information ... it has named Guido Roumans as director of global life ... management and ongoing capability enhancement in support of TechTeam,s life ...
... , MUMBAI, India , Feb. 9 ... a presence in India , Western and Central Eastern ... alliance with DreamCIS Inc., a leading CRO based in ... decade of experience in offering clinical research services to pharmaceutical ...
Cached Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 2SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 3
(Date:5/21/2013)... Global Proving Ground (GPG), a fast ... online retailer of health and fitness supplements, are partnering ... Warrior Island. “We cast the show by having ... with our unique social networking platform,” states show’s creator ... on an island in the Pacific Ocean, where they ...
(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
(Date:5/21/2013)... adenoids and tonsils, is performed 500,000 times a year ... children with obstructive sleep apnea. However, the procedure,s ... behavior, sleep apnea symptoms, and quality of life has ... led by Susan Redline, MD, MPH, director of ... Clinic Director of the Division of Sleep Medicine at ...
(Date:5/21/2013)... 2013 Go Classy Tours, the oldest ... have redesigned their website featuring N Resort in ... tubs, bars and dining. The website, which has always ... and guest reviews, will now have a broader range ... pages on culinary local recipes, flora and fauna, featured ...
(Date:5/21/2013)... The American Diabetes Association ( http://goo.gl/YRSF1 ... United States of America are affected with peripheral neuropathy. ... risk of developing peripheral neuropathy which unfortunately makes it ... further goes on saying that the disease usually affects ... million new cases are diagnosed every year in the ...
Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2
... disparities in cost-effectiveness analysis, would allow policy makers ... reduce disparities between racial ethnic subgroups, and be ... in the Journal of the National ... be used to identify effective and cost-effective strategies ...
... , TUESDAY, Sept. 6 (HealthDay News) -- Breast ... much better response to neoadjuvant chemotherapy -- chemo given ... patients, a new study finds. U.S. researchers looked ... who underwent neoadjuvant chemotherapy. Complete pathological response (pCR) ...
... HealthDay Reporter , TUESDAY, Sept. 6 (HealthDay News) -- ... ibuprofen during the first stage of their pregnancy may ... "We,re seeing a 2.4-fold increased risk in ... said Anick Berard, senior author of a paper published ...
... An innovative approach to treating neonatal feeding problems at ... to feed orally to be discharged earlier and without ... According to American Academy of Pediatrics guidelines, ... the hospital, they must establish safe oral feeding methods. ...
... in German . The stomach bacterium Helicobacter ... development of gastric cancer, the third most common cause of cancer-related ... have now identified a mechanism of Helicobacter pylori that damages the ... for malignant transformation. Gastric cancer is one of the most ...
... been prescribing codeine for postpartum pain management for many years, ... taking the opioid. But the death of an infant ... providers questioning the safety of the drug when used by ... have begun the practice of prescribing oxycodone as an alternative ...
Cached Medicine News:Health News:Modeling disparities may help with cervical cancer prevention 2Health News:Going Straight to Chemo May Be Better for Certain Breast Cancers 2Health News:NSAIDs May Raise Miscarriage Risk: Study 2Health News:NSAIDs May Raise Miscarriage Risk: Study 3Health News:Neonatal and infant feeding disorders program saves infants from lifetime of feeding tubes 2Health News:Stomach bacterium damages human DNA 2Health News:Mother's postpartum oxycodone use: No safer for breastfed infants than codeine 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: